AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34310352 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (swabs and BS)
Number of subjects: 49
Study 32719258 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous integrated boost (SIB)
Number of subjects: 24
Study 32719258 — intervention group
Group type: COMPARATOR
Intervention: Sequential boost (SEQB)
Number of subjects: 24
Study 32719258 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 35120436 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged balloon inflation in stent deployment (PBSG)
Number of subjects: 0
Study 35120436 — intervention group
Group type: COMPARATOR
Intervention: Conventional deployment strategy (CDSG)
Number of subjects: 0
Study 33212063 — intervention group
Group type: EXPERIMENTAL
Intervention: Patisiran 0.3 mg/kg by intravenous infusion every 3 weeks
Number of subjects: 211
Study 33212063 — intervention group
Group type: COMPARATOR
Intervention: APOLLO-placebo
Number of subjects: 211
Study 33212063 — intervention group
Group type: EXPERIMENTAL
Intervention: Patisiran (phase 2 OLE)
Number of subjects: 211
Study 33212063 — intervention group
Group type: EXPERIMENTAL
Intervention: APOLLO-patisiran
Number of subjects: 211
Study 33212063 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase 2 OLE patisiran
Number of subjects: 211
Study 32947644 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk for Graves' disease
Number of subjects: 473818
Study 32947644 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk for autoimmune thyroiditis
Number of subjects: 473818
Study 32947644 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk for hyperthyroidism
Number of subjects: 473818
Study 32947644 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk for hyperthyroid conditions
Number of subjects: 473818
Study 36027510 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal Denervation (RDN)
Number of subjects: 80
Study 36027510 — intervention group
Group type: COMPARATOR
Intervention: Sham Control
Number of subjects: 80
Study 34360151 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (IG) - walked to self-selected music with a predetermined tempo and received a behavioural change support programme
Number of subjects: 37
Study 34360151 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (UC)
Number of subjects: 37
Study 35266158 — intervention group
Group type: EXPERIMENTAL
Intervention: Bamboo grass (Tiliacora triandra, Diels) pellet supplementation at 0, 1, 2, 3, and 4% of dry matter substrate
Number of subjects: 0
Study 35266158 — intervention group
Group type: EXPERIMENTAL
Intervention: R:C ratio at 30:70 with BP supplementation at 4%
Number of subjects: 0
Study 32470918 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoor fitness equipment (OFE) training for 12 weeks
Number of subjects: 42
Study 32470918 — intervention group
Group type: COMPARATOR
Intervention: Control group maintaining previous lifestyles
Number of subjects: 42
Study 36380087 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo condition (inert electrical device with positive verbal information)
Number of subjects: 24
Study 36380087 — intervention group
Group type: COMPARATOR
Intervention: Control condition (inert electrical device with neutral verbal information)
Number of subjects: 24
Study 36380087 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo condition
Number of subjects: 24
Study 36380087 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 24
Study 33297773 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13 at priming and PHiD-CV at boosting (PPS)
Number of subjects: 294
Study 33297773 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13 then PHiD-CV at priming and PHiD-CV at boosting (PSS)
Number of subjects: 294
Study 33297773 — intervention group
Group type: COMPARATOR
Intervention: PHiD-CV at priming and boosting (SSS control)
Number of subjects: 294
Study 33297773 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed regimens (PPS and PSS)
Number of subjects: 294
Study 33297773 — intervention group
Group type: COMPARATOR
Intervention: PHiD-CV only
Number of subjects: 294
Study 33184861 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised process recording (self-compassion)
Number of subjects: 35
Study 33184861 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 35
Study 32323052 — intervention group
Group type: EXPERIMENTAL
Intervention: Televised football match highlights containing a high density of embedded promotion
Number of subjects: 60
Study 32323052 — intervention group
Group type: EXPERIMENTAL
Intervention: Amateur football match highlights containing no gambling-related cues or embedded promotion
Number of subjects: 60
Study 32323052 — intervention group
Group type: COMPARATOR
Intervention: Neutral control video containing footage of a live concert
Number of subjects: 60
Study 33730524 — intervention group
Group type: EXPERIMENTAL
Intervention: Monofocal intraocular lenses
Number of subjects: 29
Study 33730524 — intervention group
Group type: COMPARATOR
Intervention: Multifocal intraocular lenses
Number of subjects: 29
Study 33065589 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-Release Linaclotide 30 μg
Number of subjects: 532
Study 33065589 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-Release Linaclotide 100 μg
Number of subjects: 532
Study 33065589 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-Release Linaclotide 300 μg
Number of subjects: 532
Study 33065589 — intervention group
Group type: EXPERIMENTAL
Intervention: MD-7246 (formerly DR2) 30 μg
Number of subjects: 532
Study 33065589 — intervention group
Group type: EXPERIMENTAL
Intervention: MD-7246 (formerly DR2) 100 μg
Number of subjects: 532
Study 33065589 — intervention group
Group type: EXPERIMENTAL
Intervention: MD-7246 (formerly DR2) 300 μg
Number of subjects: 532
Study 33065589 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-Release Linaclotide 290 μg
Number of subjects: 532
Study 33065589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 532
Study 34151828 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional feedback (verbal and tactile)
Number of subjects: 180
Study 34151828 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual feedback (real-time ultrasound images)
Number of subjects: 180
Study 34151828 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 180
Study 34078268 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion tensor imaging (DTI) measurements related to the superior longitudinal fasciculus (SLF) and Anorexia nervosa (AN)
Number of subjects: 17706
Study 34078268 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion tensor imaging (DTI) measurements related to the body of the corpus callosum and Alzheimer's disease
Number of subjects: 17706
Study 34078268 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall DTI - Disorder associations
Number of subjects: 17706
Study 34078268 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion tensor imaging (DTI) measurements related to Bipolar disorder (BP)
Number of subjects: 17706
Study 34078268 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion tensor imaging (DTI) measurements related to Anorexia nervosa (AN)
Number of subjects: 17706
Study 34078268 — intervention group
Group type: EXPERIMENTAL
Intervention: Region-of-interest (ROI) analysis related to the brain region of pars triangularis and Schizophrenia
Number of subjects: 17706
Study 34078268 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall ROI - Disorder analysis
Number of subjects: 17706
Study 35160076 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mL of 20% albumin administered after induction of anesthesia
Number of subjects: 200
Study 35160076 — intervention group
Group type: COMPARATOR
Intervention: Control group (no albumin administration)
Number of subjects: 200
Study 35160076 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin group
Number of subjects: 200
Study 32429851 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab 240 mg
Number of subjects: 477
Study 32429851 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg
Number of subjects: 477
Study 32429851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 477
Study 32429851 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab (both doses combined)
Number of subjects: 477
Study 32429851 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab
Number of subjects: 477
Study 32338316 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal granisetron (granisetron patch replaced every 7 days)
Number of subjects: 75
Study 32338316 — intervention group
Group type: COMPARATOR
Intervention: Oral ondansetron (8 mg thrice daily for 72 hours after chemotherapy)
Number of subjects: 75
Study 32338316 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal granisetron
Number of subjects: 75
Study 32338316 — intervention group
Group type: COMPARATOR
Intervention: Oral ondansetron
Number of subjects: 75
Study 32338316 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal granisetron and Oral ondansetron
Number of subjects: 75
Study 35785794 — intervention group
Group type: COMPARATOR
Intervention: Children without SCA (HbAA)
Number of subjects: 3483
Study 35785794 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with known SCA
Number of subjects: 3483
Study 35785794 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with unknown SCA
Number of subjects: 3483
Study 35785794 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with SCA (both known and unknown)
Number of subjects: 3483
Study 35785794 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with SCA
Number of subjects: 3483
Study 34280468 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin plus GLP-1RA
Number of subjects: 0
Study 34280468 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin plus daily gliflozin pill
Number of subjects: 0
Study 34534029 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing about a retrospective cheerful scenario
Number of subjects: 933
Study 34534029 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing about a retrospective serious scenario
Number of subjects: 933
Study 34534029 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing about a retrospective bad mood scenario
Number of subjects: 933
Study 34534029 — intervention group
Group type: EXPERIMENTAL
Intervention: Short version of the State-Trait Cheerfulness Inventory (STCI-S)
Number of subjects: 933
Study 34534029 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard version of the State-Trait Cheerfulness Inventory (STCI-S)
Number of subjects: 933
Study 34534029 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report state measures (inspiration, self-esteem, depression, anxiety)
Number of subjects: 933
Study 32844320 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain CT scans performed without meeting the criteria of any of the standardized guidelines.
Number of subjects: 170
Study 34237311 — intervention group
Group type: EXPERIMENTAL
Intervention: Concord grape juice (CGJ)
Number of subjects: 26
Study 34237311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 33687988 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible subcutaneous catheter
Number of subjects: 20
Study 33687988 — intervention group
Group type: COMPARATOR
Intervention: Standard needles
Number of subjects: 20
Study 32808209 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle habits including consumption of low-fat foods, fish, desserts, sugary beverages, fruits, and vegetables; moderate-vigorous physical activity; steps recorded by a pedometer; sedentary behavior
Number of subjects: 178
Study 35538144 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricket-derived protein (25g)
Number of subjects: 20
Study 35538144 — intervention group
Group type: COMPARATOR
Intervention: Beef-derived protein (25g)
Number of subjects: 20
Study 33314016 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality therapy (VRT) Armeo Spring® upper limb exoskeleton (Armeo), 45 minutes daily for 3 weeks
Number of subjects: 50
Study 33314016 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy, 45 minutes daily for 3 weeks
Number of subjects: 50
Study 35197360 — intervention group
Group type: EXPERIMENTAL
Intervention: Aducanumab (30 mg/kg single dose)
Number of subjects: 0
Study 35197360 — intervention group
Group type: EXPERIMENTAL
Intervention: Aducanumab (3-10 mg/kg)
Number of subjects: 0
Study 35197360 — intervention group
Group type: EXPERIMENTAL
Intervention: Aducanumab
Number of subjects: 0
Study 35197360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36112019 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline hyclate injected at the implant-abutment interface
Number of subjects: 20
Study 36112019 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 20
Study 32634064 — intervention group
Group type: EXPERIMENTAL
Intervention: Staples
Number of subjects: 535
Study 32634064 — intervention group
Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 535
Study 36398746 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle Shortening Maneuver (MSM), n=5
Number of subjects: 10
Study 36398746 — intervention group
Group type: COMPARATOR
Intervention: Conventional Physical Therapy (CPT), n=5
Number of subjects: 10
Study 32603408 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyophilized Nile Tilapia Skin (LNTS)
Number of subjects: 24
Study 32603408 — intervention group
Group type: COMPARATOR
Intervention: Silver-impregnated sodium carboxymethylcellulose dressing
Number of subjects: 24
Study 32736660 — intervention group
Group type: EXPERIMENTAL
Intervention: Video DOT delivered via a smartphone app
Number of subjects: 0
Study 32736660 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (control)
Number of subjects: 0
Study 34605959 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine (alpha2-receptor blocker)
Number of subjects: 128
Study 34605959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 34605959 — intervention group
Group type: EXPERIMENTAL
Intervention: MDD patients
Number of subjects: 128
Study 34605959 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE
Number of subjects: 128
Study 33068366 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal cleanser containing Acanthus ebracteatus Vahl., Suregada multiflora, and Acacia concinna
Number of subjects: 30
Study 33068366 — intervention group
Group type: COMPARATOR
Intervention: Vehicle-controlled cleanser
Number of subjects: 30
Study 33895431 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided graded exercise self-help (GES)
Number of subjects: 211
Study 33895431 — intervention group
Group type: COMPARATOR
Intervention: Specialist medical care (SMC)
Number of subjects: 211
Study 33167907 — intervention group
Group type: EXPERIMENTAL
Intervention: Military-Civilian Adjustment and Reintegration Measure (M-CARM)
Number of subjects: 725
Study 35806857 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.6 g sodium butyrate daily for 12 weeks
Number of subjects: 53
Study 35806857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 34051877 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (0.5 mg twice per day for 3 days, then once per day for 27 days)
Number of subjects: 4488
Study 34051877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4488
Study 34051877 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (among PCR-confirmed COVID-19 patients)
Number of subjects: 4488
Study 34051877 — intervention group
Group type: COMPARATOR
Intervention: Placebo (among PCR-confirmed COVID-19 patients)
Number of subjects: 4488
Study 34051877 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 4488
Study 33331570 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex) treatment during surgery
Number of subjects: 86
Study 33331570 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex) treatment
Number of subjects: 86
Study 33331570 — intervention group
Group type: COMPARATOR
Intervention: Routine anesthesia (Control)
Number of subjects: 86
Study 35442064 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily
Number of subjects: 0
Study 35442064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35442064 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0
Study 33749349 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation program (n=30)
Number of subjects: 117
Study 33749349 — intervention group
Group type: COMPARATOR
Intervention: Standard care control (n=28)
Number of subjects: 117
Study 32092167 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse-based diet (lentils, beans, split peas and chickpeas)
Number of subjects: 61
Study 32092167 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic Lifestyle Changes (TLC) diet
Number of subjects: 61
Study 33484625 — intervention group
Group type: EXPERIMENTAL
Intervention: HK$0 fee group
Number of subjects: 239
Study 33484625 — intervention group
Group type: EXPERIMENTAL
Intervention: HK$150 fee group
Number of subjects: 239
Study 33484625 — intervention group
Group type: COMPARATOR
Intervention: HK$300 fee group
Number of subjects: 239
Study 32650345 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypectomy Efficiency (PE)
Number of subjects: 20
Study 32650345 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoplastic Polypectomy Efficiency (NPE)
Number of subjects: 20
Study 34890047 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene Citrate (CC) 100 mg/day
Number of subjects: 501
Study 34890047 — intervention group
Group type: COMPARATOR
Intervention: Letrozole (L) 5 mg/day
Number of subjects: 501
Study 34890047 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (L) 2.5 mg/day + Clomiphene Citrate (CC) 50 mg/day
Number of subjects: 501
Study 34886482 — intervention group
Group type: EXPERIMENTAL
Intervention: Ai-Chi practice
Number of subjects: 19
Study 34886482 — intervention group
Group type: COMPARATOR
Intervention: Structured on-land Ai-Chi practice
Number of subjects: 19
Study 34886482 — intervention group
Group type: COMPARATOR
Intervention: Guided-imagery of Ai-Chi practice
Number of subjects: 19
Study 32125110 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined individual-collective debriefing
Number of subjects: 30
Study 32125110 — intervention group
Group type: COMPARATOR
Intervention: Standard collective debriefing
Number of subjects: 30
Study 35274407 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐MCT (Metacognitive Training for Depression)
Number of subjects: 75
Study 35274407 — intervention group
Group type: COMPARATOR
Intervention: Euthymic therapy (active control)
Number of subjects: 75
Study 34354699 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidrug therapy (MDT) comprising rifampicin, dapsone, and clofazimine, 12 doses
Number of subjects: 0
Study 34354699 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidrug therapy (MDT)
Number of subjects: 0
Study 34354699 — intervention group
Group type: EXPERIMENTAL
Intervention: CXCL10 (IP‐10)
Number of subjects: 0
Study 32151918 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week exercise program combining weekly group sessions and home-based exercises (2/week) focusing on motor learning, flexibility, strengthening, and balance.
Number of subjects: 210
Study 32151918 — intervention group
Group type: COMPARATOR
Intervention: Placebo ultrasound given once a week.
Number of subjects: 210
Study 32151918 — intervention group
Group type: COMPARATOR
Intervention: Non-treated control group.
Number of subjects: 210
Study 35525784 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-physical activity program (2 weekly sessions of 1 hour of physical exercise for 4 months; monthly sessions on healthy habits; 3 days of social activities)
Number of subjects: 102
Study 35525784 — intervention group
Group type: COMPARATOR
Intervention: Usual advice (Control group)
Number of subjects: 102
Study 33301362 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote monitoring (RM) with appropriate contacts to FTC alerts
Number of subjects: 505
Study 33301362 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 505
Study 35750597 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined anterior and posterior ring (APR) fixation
Number of subjects: 40
Study 35750597 — intervention group
Group type: COMPARATOR
Intervention: Isolated posterior ring (PR) fixation
Number of subjects: 40
Study 33891718 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Family Intervention (BFI)
Number of subjects: 40
Study 33891718 — intervention group
Group type: COMPARATOR
Intervention: Control (no BFI)
Number of subjects: 40
Study 33891718 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions (BFI and Control)
Number of subjects: 40
Study 32960889 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+Probiotic (Bifidobacterium animalis subsp. lactis HN019)
Number of subjects: 30
Study 32960889 — intervention group
Group type: COMPARATOR
Intervention: SRP+Placebo
Number of subjects: 30
Study 35670065 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent theta-burst stimulation (iTBS)
Number of subjects: 50
Study 33258049 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal and traditional mass media sources
Number of subjects: 1001
Study 33258049 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related media such as pharmacy magazines
Number of subjects: 1001
Study 33258049 — intervention group
Group type: EXPERIMENTAL
Intervention: Health professionals
Number of subjects: 1001
Study 33258049 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet
Number of subjects: 1001
Study 32712155 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin‐paclitaxel + nintedanib
Number of subjects: 119
Study 32712155 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin‐paclitaxel
Number of subjects: 119
Study 35435875 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson relaxation technique combined with music therapy
Number of subjects: 61
Study 32630191 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide (10 mcg)
Number of subjects: 30
Study 32630191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35263280 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratracheal oxygen administration
Number of subjects: 6